The time between the diagnosis of malignant melanoma and the occurrence of distant metastases did not differ between the two patient groups, but the median survival of patients with newly diagnosed metastatic melanoma was 5.7 months in patients with BRAF mutation (patients not treated with BRAF inhibitors), compared to 8.5 months in patients without the mutation. Here, BRAF is linked to metastatic melanoma.